Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2025-12-25 @ 4:52 AM
NCT ID:
NCT00400218
Eligibility Criteria:
Inclusion Criteria:
* Patient is either receiving high blood pressure monotherapy or no treatment
* Patient will have reached the legal age by the time enter the study
* Patients diagnosed with mild to moderate essential high blood pressure or high blood pressure with other conditions such as diabetes or cardiovascular diseases and are taking high blood pressure medication (exclude diuretic), but did not meet treatment goal
Exclusion Criteria:
* Patient with high levels of uric acid in the blood who has received medications for uric acid in the urine within 3 months prior to enrollment
* Patients who are hypersensitive to any component of the study medication
* Patients who are hypersensitive to other sulfonamide-derived drugs
* Patients with anuria (hyzaar(R) is not recommended for patients with hepatic impairment or severe renal impairment, creatinine clearance \</= 30 ml/min)
* Unstable diabetes (hba1c \> 8%), or a change in diabetes medication during study treatment. patients with stable diabetes may enter the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00400218
Study Brief:
Protocol Section:
NCT00400218